EcoDrugPlus

Integrin Alpha-5-Like

Ensembl ID : ENSDCDG00000021261
Gene Symbol: LOC114798470
3 Cross references
206 Possible Orthologues:

Integrin Alpha-Iib-Like

Ensembl ID : ENSDCDG00000008459
Gene Symbol: LOC114794901
3 Cross references
191 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSDCDG00000034014
Gene Symbol: LOC114769394
2 Cross references
159 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSDCDG00000006483
Gene Symbol: LOC114772446
2 Cross references
159 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSDCDG00000005008
Gene Symbol: LOC114794222
3 Cross references
204 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSDCDG00000035780
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSDCDG00000021357
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSDCDG00000035381
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSDCDG00000022976
Gene Symbol: ITGB1
3 Cross references
230 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSDCDG00000016909
Gene Symbol: ITGB3
3 Cross references
195 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSDCDG00000018672
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSDCDG00000004139
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).